NEURO2022

Session information

Poster

[2P] A. Neural Excitability, Synapses, and Glia: Cellular Mechanisms

Fri. Jul 1, 2022 11:00 AM - 12:00 PM Poster Session Hall 2 (Ginowan City Gymnasium)

*Tomoki Osuka1, Hiroaki Wake3, Etsuo Susaki4,2, Katsuhiko Matsumoto2, Takeshi Yagi1 (1. Grad Sch FBS, Univ of Osaka, Osaka, Japan, 2. Laboratory for Synthetic Biology, RIKEN Center for Biosystems Dynamics Research, Osaka, Japan, 3. Grad Sch Med, Univ of Nagoya,Nagoya, Japan, 4. Grad Sch Med, Univ of Juntendo, Tokyo, Japan)

*Hiroyuki Kanayama1,2, Takako Fukuda1, Takashi Tominaga3, Yoko Tominaga3, Nobuo Kato4, Hiroshi Yoshimura1 (1. Department of Molecular Oral Physiology, Institute of Biomedical Sciences, Tokushima University Graduate School, 2. National Hospital Organization Osaka National Hospital, Oral and Maxillofacial Surgery, 3. Institute of Neuroscience, Tokushima Bunri University, 4. Department of Physiology, Kanazawa Medical University)

*Yuta Ishizuka1,5, Tadiwos F. Mergiya1,2, Rodolfo Baldinotti1,2, Ju Xu1, Erik I. Hallin1, Sigurbjörn Markússon1, Petri Kursula1,3,4, Clive R. Bramham1,2 (1. Dept Biomed, Univ of Bergen, Bergen, Norway, 2. Mohn Ctr for Res on the Brain, Univ of Bergen, Bergen, Norway, 3. Fac Biochem & Mol Med, Univ of Oulu, Oulu, Finland, 4. Biocenter Oulu, Univ of Oulu, Oulu, Finland, 5. Dept Pathophysiol & Metab, Kawasaki Med Sch, Kurashiki, Okayama)

*Maki K. Yamada1,2, Kazuya Kuboyama1,4, Takeshi Kubota1,2, Miku Yoshioka1, Otoha Nakatani1, Toshie Fujishima3, Shungo Adachi5, Tohru Natsume5 (1. Neuropharmacol, Kagawa Pharma Sci, Tokushima Bunri Univ, Kagawa, Japan, 2. Neuropharmacol, Inst Neurosci, Tokushima Bunri Univ, 3. Med Chem, Kagawa Pharma Sci, Tokushima Bunri Univ, 4. Dev Regen Neurobio, Inst Brain Sci, Grad Sch Med, Nagoya City Univ, 5. Cell Mol Biotech Res Inst, AIST)

*Ana Filipa Terceiro1,2, Andrea Lobo1, Lia Carvalhais3,4, Miguel Aroso5, Mafalda Sousa6, Ana Magalhães1, Paulo Aguiar5, João Relvas7,8, Teresa Summavielle1,9 (1. Addiction Biology Group, i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, 2. Instituto de Ciências Biomédicas Abel Salazar (ICBAS), Universidade do Porto, Porto, Portugal, 3. Center for Neuroscience and Cell Biology, University of Coimbra, Coimbra, Portugal, 4. Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal, 5. Neuroengineering and Computational Neuroscience, i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, 6. i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, 7. Glial Cell Biology, i3S – Instituto de Investigação e Inovação em Saúde, Universidade do Porto, Porto, Portugal, 8. Faculdade de Medicina da Universidade do Porto (FMUP), Porto, Portugal, 9. ESS.PP, Escola Superior de Saúde do Politécnico do Porto, Porto, Portugal)

*Shingo Koinuma1, Misa Miyaji1, Akira Hoshina1,2, So Maezawa2, Naoyuki Wada2, Hiroshi Takemura2, Yoshiki Koriyama3, Sumiko Kiryu-Seo4, Hiroshi Kiyama4, Michihiro Igarashi5, Takeshi Nakamura1 (1. RIBS, Tokyo Univ of Sci, Chiba, Japan, 2. Faculty of Sci and Tech, Tokyo Univ of Sci, Chiba, Japan, 3. Faculty of Pharm Sci, Suzuka Univ of Med Sci, Mie, Japan, 4. Grad Sch of Med, Nagoya Univ, Aichi, Japan, 5. Grad Sch of Med and Dental Sci, Niigata Univ, Niigata, Japan)

*Tatsuya Manabe1,2, Ildiko Racz1,2, Stephanie Schwartz1,2, Francesco Santarelli2, Julius V. Emmrich3, Jonas J. Neher4,5, Michael T. Heneka1,2,6 (1. Department of Neurodegenerative Diseases and Geriatric Psychiatry, University of Bonn Medical Center, Bonn, Germany, 2. German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany, 3. Department of Neurology and Experimental Neurology, Charite – Universitatsmedizin Berlin, Berlin, Germany, 4. Department of Cellular Neurology, Hertie Institute for Clinical Brain Research, University of Tubingen, Tubingen, Germany, 5. German Center for Neurodegenerative Diseases (DZNE), Tubingen, Germany, 6. Department of Infectious Diseases and Immunology, University of Massachusetts Medical School, Worcester, Massachusetts, USA)

*Rui Mizutani1, Asuka Tomiyama1, Takeshi Imai1, Sayoko Matsushita1, Ayako Morita1, Eriko Urano1, Miho Sato-Hashimoto2, Yuriko Hayashi3, Takashi Matozaki4, Hiroshi Ohnishi1 (1. Gunma Univ Grad Sch Health Sci, Gunma, Japan, 2. Sch Pharm Sci, Kyushu Univ Health Welfare, Miyazaki, Japan, 3. Gunma Paz Univ Grad Sch Health Sci, Gunma, Japan, 4. Kobe Univ Grad Sch Med, Kobe, Japan)

*Ritsuko Shimogawa1, Akira Sobue1,2, Okiru Komine1, Ayaka Ito3,4, Takayoshi Suganami3, Koji Yamanaka1 (1. Department of Neuroscience and Pathobiology, Research Institute of Environmental Medicine, Nagoya University, 2. Medical Interactive Research and Academia Industry Collaboration Center, Research Institute of Environmental Medicine, Nagoya University, 3. Department of Molecular Medicine and Metabolism, Research Institute of Environmental Medicine, Nagoya University, 4. Institute for Advanced Research, Nagoya University)

*Takeshi Shimizu1, Aoi Sato1, Mitsuki Kokuryoh1, Shinya Ueno1, Kenta Kobayashi2,3, Hideki Hida1 (1. Department of Neurophysiology and Brain Science, Graduate School of Medical Sciences, Nagoya City University, 2. Section of Viral Vector Development, National Institute for Physiological Sciences, 3. Graduate University of Advanced Studies (SOKENDAI))

*Yuta Ochi1, Wakiko Arakaki2, Di Hu1, Danxi Li1, Mika Shigeta1, Emi Hayashinaka3, Yasuhiro Wada3, Hisashi Doi2, Yasuyoshi Watanabe3, Yilong Cui1 (1. Laboratory for Biofunction Dynamics Imaging, RIKEN Center for Biosystems Dynamics Research, 2. Laboratory for Labeling Chemistry, RIKEN Center for Biosystems Dynamics Research, 3. Laboratory for Pathophysiological and Health Science, RIKEN Center for Biosystems Dynamics Research)

*Katherine Picard1,2, Janine Kox6, Eva Šimončičová2, Robbert Havekes6, Marie-Eve Tremblay1,2,3,4,5 (1. Dept Med moléculaire, Univ Laval, Québec, Qc, Canada, 2. Division of Medical Sciences, Univ of Victoria, Victoria, BC, Canada, 3. Dept of Biochemistry and Molecular Biology, Univ of British Columbia, Vancouver, BC, Canada, 4. Dept of Neurology and Neurosurgery, McGill Univ, Montréal, QC, Canada, 5. Centre for Advanced Materials and Related Technology (CAMTEC), Univ of Victoria, Victoria, BC, Canada, 6. Neurobiology expertise group, Groningen Institute for Evolutionary Life Sciences, Univ of Groningen, Groningen, The Netherlands)

*Hanae Morio1, Keita Kitamura1,2, Ayaka Okamoto1, Ryo Ito3, Yoshiyuki Yamaura4, Takafumi Komori5, Tomomi Furihata1 (1. Lab. Clin. Pharm. & Exp. Therap., Sch. Pharmacy., Tokyo Univ. Pharm. & Life Sci., 2. Lab. DDS Design & Drug Dispos., Grad. Sch. Pharm. Sci., Chiba Univ., 3. Res. Ctr. Neurol., Ono Pharm. Co., Ltd., 4. Dept. Pharmacokinet. Res., Ono Pharm. Co., Ltd., 5. Dept. Drug Metab. & Pharmacokinet., Eisai Co. Ltd.)

*Ryosuke Kaneko1, Manabu Abe2, Yukiko Ueno Inoue3, Yusuke Takatsuru4, Masahiko Watanabe5, Kenji Sakimura2, Yuchio Yanagawa6, Takeshi Yagi1 (1. FBS, Osaka Univ, Osaka, Japan, 2. BRI, Niigata Univ, Niigata, Japan, 3. Dep of Biochem and Cellular Biol, National Institute of Neurosci, Tokyo, Japan, 4. Toyo Univ, Dept Nutr Health Sci, Gunma, Japan, 5. Grad Sch Med, Hokkaido Univ, Hokkaido, Japan, 6. Grad Sch Med, Gunma Univ, Gunma, Japan)

*Yoshiko Honda1, Tetsuya Shimokawa2, Seiji Matsuda2, Yasushi Kobayashi3, Keiko Moriya-Ito4 (1. Dept Anat & Neurobiol, Sch Med, Tokyo Women’s Med, Univ, Tokyo, Japan, 2. Div Anat & Embryol, Dept Funct Biomed, Ehime Univ, Toon, Japan, 3. Dept Anat & Neurobiol, National Defense Med Col, Tokorozawa, Japan, 4. Dept Brain Development & Neural Regeneration, Tokyo Metropol Inst Med Sci, Tokyo, Japan)

×

Authentication

×

Please log in with your participant account.
» Participant Log In